Literature DB >> 4618453

Antibacterial activity of lividomycin toward R factor-resistant strains of Escherichia coli.

M Yamaguchi, F Kobayashi, S Mitsuhashi.   

Abstract

Forty-eight R factors conferring resistance to both kanamycin (KM) and streptomycin (SM) were demonstrated from 1,270 Escherichia coli strains of clinical origin. Among these R factors isolated, 42 also conferred resistance to the new antibiotic lividomycin (LV). Extracts of E. coli ML1410 carrying one such factor (R(M81)) inactivated LV as well as KM and SM. But extracts of E. coli ML1410 carrying an R factor (R(M82) or R(M83)) sensitive to LV could not inactivate LV. LV inactivation required both adenosinetriphosphate (ATP) and Mg(2+). Inactivated LV was reactivable by alkaline phosphatase. Isotopic studies with labeled ATP and elemental analysis of the reaction product indicate that it is a monophosphorylated derivative of LV.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4618453      PMCID: PMC444182          DOI: 10.1128/AAC.1.2.139

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

1.  Adenylylstreptomycin, a product of streptomycin inactivated by E. coli carrying R factor.

Authors:  H Umezawa; S Takasawa; M Okanishi; R Utahara
Journal:  J Antibiot (Tokyo)       Date:  1968-01       Impact factor: 2.649

2.  Isolation of kanamycin and paromamine inactivated by E. coli carrying R factor.

Authors:  S Kondo; M Okanishi; R Utahara; K Maeda; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1968-01       Impact factor: 2.649

3.  Enzymatic inactivation of streptomycin by R factor-resistant Escherichia coli.

Authors:  T Yamada; D Tipper; J Davies
Journal:  Nature       Date:  1968-07-20       Impact factor: 49.962

4.  Phosphorylation and inactivation of aminoglycosidic antibiotics by E. coli carrying R factor.

Authors:  K Okanishi; S Kondo; R Utahara; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1968-01       Impact factor: 2.649

5.  Isolation of paromamine inactivated by Pseudomonas aeruginosa.

Authors:  K Maeda; S Kondo; M Okanishi; R Utahara; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1968-07       Impact factor: 2.649

6.  Phosphorylation and inactivation of kanamycin by Pseudomonas aeruginosa.

Authors:  H Umezawa; O Doi; M Ogura; S Kondo; N Tanaka
Journal:  J Antibiot (Tokyo)       Date:  1968-02       Impact factor: 2.649

7.  Inactivation and phosphorylation of kanamycin by drug-resistant Staphylococcus aureus.

Authors:  O Doi; M Miyamoto; N Tanaka; H Umezawa
Journal:  Appl Microbiol       Date:  1968-09

8.  Purification and properties of kanamycin-phosphorylating enzyme from Pseudomonas aeruginosa.

Authors:  O Doi; S Kondo; N Tanaka; H Umezawa
Journal:  J Antibiot (Tokyo)       Date:  1969-06       Impact factor: 2.649

9.  Resistance factor-mediated streptomycin resistance.

Authors:  J H Harwood; D H Smith
Journal:  J Bacteriol       Date:  1969-03       Impact factor: 3.490

10.  Inactivation of kanamycin, neomycin, and streptomycin by enzymes obtained in cells of Pseudomonas aeruginoa.

Authors:  O Doi; M Ogura; N Tanaka; H Umezawa
Journal:  Appl Microbiol       Date:  1968-09
View more
  3 in total

1.  Phosphorylation of kanamycin, lividomycin A, amd butirosin B by Providencia stuartii.

Authors:  P B Marengo; M E Chenoweth; G D Overturf; J Wilkins
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

2.  Lividomycin resistance in staphylococci by enzymatic phosphorylation.

Authors:  F Kobayashi; T Koshi; J Eda; Y Yoshimura; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1973-07       Impact factor: 5.191

3.  Phosphorylation of lividomycin by Escherichia coli carrying an R factor.

Authors:  M Yamaguchi; T Koshi; F Kobayashi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.